In the vast tapestry of India’s healthcare landscape, the diagnostics industry emerges as a dynamic force, weaving together technological advancements, changing patient expectations, and an ever-expanding vision for a healthier nation. Indian diagnostics sector itself is projecting INR 1,360 Bn market until FY2026, increasing at 14% CAGR, with the mix of 60% pathology & 40% Imaging/Radiology. The journey of this sector is not merely a chronological progression but a complex interplay of factors that are reshaping the contours of healthcare delivery.

At the heart of this evolution lies the ongoing narrative of the huge gap of service quality between unorganized to organized diagnostics service providers. It is surprising that in an era where almost the entire spectrum – right from medicine manufacturers to junk food chains are governed by regulations, the diagnostics sector does not receive as much scrutiny from regulatory bodies. The industry and regulatory authorities need to work together to put in place and enable adoption of regulatory certifications/licenses such as Consent to Establish (CTE) & Consent to Operate (CTO).

Today, only 17 % diagnostic service providers are from the organized sector, 37% are hospital-based labs and a whopping 46% are from the unorganized standalone labs. The organized segment brings a new paradigm – one defined by standardization, adherence to stringent quality protocols, and the integration of advanced diagnostic technologies. A transition focusing on organizing the sector is a need of the hour, and a move in this direction will be a testament to the industry’s commitment to providing reliable, consistent, and quality-driven diagnostic services.

Focus on Accredited/Certified Labs:
Even more surprising is that in India, only 3%, labs are NABL accredited, and reporting accuracy is a major concern. This is the scenario, despite the fact that about 70% of treatment decisions are based on diagnostics tests. Within this landscape, the spotlight on accredited and certified labs is becoming more pronounced. Patients, recognizing the significance of report accuracy, are gravitating towards labs that have undergone stringent accreditation processes. The industry’s pivot towards accredited labs is, therefore, not just a nod to regulatory requirements but also a proactive commitment to instilling confidence in patients regarding the reliability of diagnostic results.

Increasing Patient Awareness:
In tandem with this evolution is the rise in awareness among patients about the pivotal role of accurate diagnostic services in their healthcare journey. Patients, armed with information and an increasing sense of agency, are no longer passive recipients of medical care. Instead, they are actively seeking comprehensive diagnostic evaluations, understanding the intrinsic link between early detection and effective healthcare outcomes. This heightened awareness is a catalyst for a cultural shift towards a preventive and proactive healthcare mindset.

Leveraging Technology:
In the mosaic of the diagnostics industry’s evolution, technology stands out as a transformation driver. From the digitization of patient records to the advent of sophisticated diagnostic tools, technology is reshaping the patient experience. The seamless integration of technology not only enhances operational efficiency for diagnostic labs but, more importantly, provides patients with a more accessible, convenient, and transparent healthcare journey. This technological integration signifies not just a modernization of processes but a paradigm shift towards a more patient-centric approach.

The forefront of diagnostics is witnessing unprecedented breakthroughs in molecular diagnostics, genetic testing and point-of-care testing. Artificial intelligence and machine learning are redefining diagnostic precision and efficiency, setting the stage for a new era of medical insight.

Data analytics is becoming the cornerstone of diagnostic decision-making. The shift towards personalized medicine, driven by individual patient data, is not only reshaping treatment plans but also revolutionizing the entire diagnostic process. The future lies in diagnostics that are tailored to the unique needs of each patient and help doctors get historical trends, thereby enabling customized treatment plans. Moreover, theindustry should leverage AI-driven tools to offer patients complete transparency w.r.t. their health check-ups and to maintain patient dataauthenticity.

Patient Centricity:
Expanding the canvas of patient-centricity beyond clinic walls, the industry is embracing innovations that redefine the patient experience. In India, 60-70% of errors in the diagnostics sector happen at pre-analytical level and this needs immediate attention.

Temperature-controlled sample movement bundled with free home sample collection services, smart reports and trend analysis reports that decode complex medical jargon, and the analysis of historical patient trends are becoming integral facets of diagnostics. These innovations empower patients by offering unparalleled convenience, best-in-class experience, and a deeper understanding of their health data, catalyzing a paradigm shift towards a more engaged and proactive approach to well-being.

In India, the prevalence of Non-Communicable Diseases (NCD) on the rise over the past few years. Currently, NCDs contribute to 62% of deaths in India (up from 37% in 1990). One out of four adults in India has hypertension. This prevalence can be monitored and addressed through patient’s trend analysis report, which will help doctors to offer accurate treatment to patients.

Preventive Diagnostics and Test Packages:
An undeniable current in this evolutionary tide is the industry’s pivot toward preventive diagnostics. Diagnostic test packages tailored for preventive care are gaining prominence, reinforcing the notion that health is not merely the absence of disease but a holistic state of well-being. This shift towards a proactive approach is instrumental in identifying potential health issues before they escalate, thereby contributing significantly to overall wellness and reducing the burden on the healthcare system.

Post Covid, there has been greater attention towards health, and patients are proactively availing preventive health checkups. However, despite the increase, this only contributes 10-12% of total diagnostics testing of India. This scenario needs a change and preventive health checkups should be considered as a first step toward long-term good health. In addition, it is very important that health checkups should be conducted only from accredited labs to avoid misleading reports.

Enabling High-Quality Diagnostics in Tier 2 and Tier 3 Cities:
In India, 30-35% diagnostics testing is performed in metro cities and less than half of these tests are performed by organized diagnostics labs. Going beyond metro cities, the industry is actively dismantling barriers to access, ensuring that the benefits of high-quality diagnostics are not confined to urban centers. This commitment to extending quality healthcare services to tier 2 and tier 3 cities, and beyond, is not just a geographic expansion but a stride towards creating a more inclusive and equitable healthcare system. It is a narrative of democratization, where individuals, irrespective of their location, have access to the same level of diagnostic expertise.

In conclusion, the evolution of the diagnostics industry in India is not merely a journey from point A to point B; it is a nuanced narrative of adaptation and transformation. From the dichotomy of organized and unorganized labs to the pervasive influence of technology and the empowerment of patients, the industry is actively responding to the changing needs and expectations of a populace that aspires for a healthier tomorrow. As we traverse this path towards a future where diagnostics play a pivotal role in shaping healthcare outcomes, the industry’s commitment to quality, accessibility, and patient-centricity will undoubtedly pave the way for a healthier and more informed society.

This article was first published in the ET Healthworld on 27th December 2023